This Servier arranged webinar is for hematologists. The agenda for the webinar is:
12:00-12:05 – Introduction by Erik Holgén, Product Manager, Servier
12:05-12:30 – Prof. Dr. Michael Heuser – Will present the AGILE study and the clinical implications of the study results.
12:30-12:45 – Docent Vladimir Lazarevic – Focusing on treatment of mIDH1 AML patients in the future
12:45-13:00 – Questions & Answers
——————-
Unable to attend at this time? Register anyway to receive the recording afterwards.